Project
| ID | INDIGO-POJ-0315 |
|---|---|
| Impact Bond Name - (Value) | Development Impact Bond (DIB) for hepatitis C diagnosis and treatment financing - Cameroon |
| Stage of Development - (Value) | Complete |
| Stage of Development - (Source ID's) | source1 |
| Dates - Date outcomes contract signed - (Value) | 2019-12 |
| Dates - Date contracts between all parties signed - (Value) | 2020-01 |
| Dates - Anticipated duration of service provision - (Value) | 24 |
| Dates - (Source ID's) | source1 |
| Overall project finance - Total investment commitment - Currency - (Value) | EUR |
| Overall project finance - Total investment commitment - Amount - Exact - (Value) | 230000 |
| Overall project finance - Total investment commitment - Amount USD - Exact - (Value) | 261364 |
| Overall project finance - Maximum potential outcome payment - Currency - (Value) | EUR |
| Overall project finance - Maximum potential outcome payment - Amount - (Value) | 397800 |
| Overall project finance - Maximum potential outcome payment - Amount USD - (Value) | 452046 |
| Overall project finance - (Source ID's) | source1 |
| Investment Details - (Source ID's) | source1 |
| Purpose and classifications - Social challenge - (Value) | High rates of undiagnosed and untreated chronic HCV infection, a treatable condition, in Cameroon |
| Purpose and classifications - Policy sector - (Value) | Health |
| Purpose and classifications - Primary SDG goal - (Value) | 3 |
| Purpose and classifications - (Source ID's) | source1 |
| Service and beneficiaries - Target population - (Value) | HCV-infected individuals (carriers) |
| Service and beneficiaries - Actual number of unique service users or beneficiaries engaged (total) - (Value) | 300 |
| Service and beneficiaries - Unit type of actual service users or beneficiaries engaged - (Value) | Individual |
| Service and beneficiaries - Unit description of actual service user or beneficiaries engaged - (Value) | HCV-infected individuals (carriers) |
| Service and beneficiaries - (Source ID's) | source1 |
| Service and beneficiaries - (Notes) | The target was to identify around 500 antibody-HCV positive donors to enroll the planned 300 HCV- infected persons. Of the 500 antibody-HCV positive donors, it was assumed that 25% would have cleared the virus by themselves (i.e. antibody-HCV positive and HCV-RNA negative), 10% would be false positive (first anti-HCV testing in blood bank positive but not confirmed in second test) and about 10% will be lost to follow-up. |
| Changes to project due to COVID-19 - (Value) | Continue on outcomes contract with variations |
| Changes to project due to COVID-19 - (Source ID's) | source1 |
| Notes - (Value) | The study was launched just before the COVID-19 pandemic and enrollment of patients was paused for six months. To continue the project, three agents – the investor, intermediary and outcome payer – agreed to invest additional money in the DIB. The total unexpected costs due to COVID-19 was €72,500 and was paid directly into the project as a once-off payment in January 2021. |
| Delivery Locations 1: Service Provision ID - (Value) | deliverylocation1 |
| Delivery Locations 1: Location - Name - (Value) | Cameroon, Yaoundé |
| Delivery Locations 1: Location - Country - (Value) | CM |
| Delivery Locations 1: Lat/Lng - Lat - (Value) | 3.8617 |
| Delivery Locations 1: Lat/Lng - Lng - (Value) | 11.5202 |
| Sources 1: Id | source1 |
| Sources 1: Name - (Value) | Research Paper: A small-scale ‘Development Impact Bond’ for hepatitis C diagnosis and treatment financing in Cameroon: the way to elimination? |
| Sources 1: Type - (Value) | Report |
| Sources 1: URL - (Value) | https://www.joghr.org/article/90723-a-small-scale-development-impact-bond-for-hepatitis-c-diagnosis-and-treatment-financing-in-cameroon-the-way-to-elimination |
| Sources 1: Publication Date - (Value) | December 11, 2023 |
| Sources 1: Accessed Date - (Value) | January 22nd, 2024 |
| Service Provisions 1: Id | serviceprovision1 |
| Service Provisions 1: Organisation ID - (Value) | INDIGO-ORG-1613 |
| Service Provisions 1: Organisation Role Category - (Value) | Government/Public Sector/Public Bank |
| Service Provisions 2: Id | serviceprovision2 |
| Service Provisions 2: Organisation ID - (Value) | INDIGO-ORG-1614 |
| Service Provisions 2: Organisation Role Category - (Value) | Government/Public Sector/Public Bank |
| Outcome Payment Commitments 1: Organisation ID - (Value) | INDIGO-ORG-1616 |
| Outcome Payment Commitments 1: Organisation Role Category - (Value) | Foundation/Philanthropist |
| Outcome Payment Commitments 1: Maximum potential Outcome payment - Currency - (Value) | EUR |
| Outcome Payment Commitments 1: Maximum potential Outcome payment - Amount - (Value) | 397800 |
| Outcome Payment Commitments 1: Maximum potential Outcome payment - Amount USD - (Value) | 377910 |
| Outcome Payment Commitments 1: Result type - (Value) | Overall |
| Outcome Payment Commitments 1: Total outcome payments made - Currency - (Value) | EUR |
| Outcome Payment Commitments 1: Total outcome payments made - Amount - (Value) | 397800 |
| Outcome Payment Commitments 1: Total outcome payments made - Amount USD - (Value) | 377910 |
| Investments 1: Id | investment1 |
| Investments 1: Organisation ID - (Value) | INDIGO-ORG-1610 |
| Investments 1: Organisation Role Category - (Value) | Investment Fund |
| Investments 1: Investment Commitment - Currency - (Value) | EUR |
| Investments 1: Investment Commitment - Amount - Min - (Value) | 230000 |
| Investments 1: Investment Commitment - Amount - Exact - (Value) | 230000 |
| Investments 1: Investment Commitment - Amount USD - Exact - (Value) | 218500 |
| Investments 1: Notes | Actual total investment (capital recycling) was 339,574 EURO (Total interest of 17,150 EURO and fees of 2,300 EURO) |
| Intermediary services 1: Organisation ID - (Value) | INDIGO-ORG-1611 |
| Intermediary services 1: Organisation Role Category - (Value) | Other |
| Intermediary services 2: Organisation ID - (Value) | INDIGO-ORG-1612 |
| Intermediary services 2: Organisation Role Category - (Value) | Other |
| Intermediary services 3: Organisation ID - (Value) | INDIGO-ORG-1615 |
| Intermediary services 3: Organisation Role Category - (Value) | Other |
| Intermediary services 3: Other Role Description - (Value) | Evaluator |
| Outcome Metrics 1: Id | outcomemetric1 |
| Outcome Metrics 1: Outcome Definition - (Value) | Patients enrolled in the program (treated for HCV) |
| Outcome Metrics 1: Target Population - (Value) | HCV-infected individuals (carriers) |
| Outcome Metrics 1: Targeted number of service users Or beneficiaries (total) - (Value) | 300 |
| Outcome Metrics 1: Unit type of targeted Service users or beneficiaries - (Value) | Individual |
| Outcome Metrics 1: Policy sector - (Value) | Health |
| Outcome Metrics 1: Primary SDG goal - (Value) | 3 |
| Outcome Metrics 2: Id | outcomemetric2 |
| Outcome Metrics 2: Outcome Definition - (Value) | Patients cured of HCV (negative HCV viral load), as certified by the outcome validator |
| Outcome Metrics 2: Target Population - (Value) | HCV-infected individuals (carriers) |
| Outcome Metrics 2: Targeted number of service users Or beneficiaries (total) - (Value) | 300 |
| Outcome Metrics 2: Unit type of targeted Service users or beneficiaries - (Value) | Individual |
| Outcome Metrics 2: Policy sector - (Value) | Health |
| Outcome Metrics 2: Primary SDG goal - (Value) | 3 |
| Outcome Metrics 2: Notes | The outcome payor reimbursed the investor only in case of good performance, defined as cured patients (HCV-RNA negative) |
| Outcome Pricings 1: Outcome Metric Id - (Value) | outcomemetric1 |
| Outcome Pricings 1: Currency - (Value) | EUR |
| Outcome Pricings 1: Price Per Unit - Amount - (Value) | 1542 |
| Outcome Pricings 1: Price Per Unit - Amount USD - (Value) | 1464.9 |
| Outcome Pricings 2: Outcome Metric Id - (Value) | outcomemetric2 |
| Outcome Pricings 2: Currency - (Value) | EUR |
| Outcome Pricings 2: Price Per Unit - Amount - (Value) | 1630 |
| Outcome Pricings 2: Price Per Unit - Amount USD - (Value) | 1548.5 |
| Outcome Pricings 2: Notes | Eventual outcome: Patients enrolled in the program cured of HCV (negative HCV viral load), as certified by the outcome validator |
| Results 1: Outcome Metric Id - (Value) | outcomemetric1 |
| Results 1: Result level - (Value) | Outcome level |
| Results 1: Result type - (Value) | Final |
| Results 1: Period - Start - (Value) | 2020-01 |
| Results 1: Outcomes achieved - (Value) | Of the 258 individuals who started treatment, 253 (98%) completed the treatment at week 12. |
| Results 1: Number engaged In impact bond - (Value) | 258 |
| Results 1: Number with Positive social outcomes - (Value) | 253 |
| Results 1: Evaluation Documents - (Value) | source1 |
| Results 2: Outcome Metric Id - (Value) | outcomemetric2 |
| Results 2: Result level - (Value) | Outcome level |
| Results 2: Result type - (Value) | Final |
| Results 2: Period - Start - (Value) | 2020-01 |
| Results 2: Outcomes achieved - (Value) | At week 24, 244/253 (96%) are cured, and 8 out of the 9 individuals – one person refused – who were not cured at week 24 received second-line treatment for 12 weeks. All 8 were cured 12 weeks later. |
| Results 2: Number engaged In impact bond - (Value) | 258 |
| Results 2: Number with Positive social outcomes - (Value) | 253 |
| Results 2: Evaluation Documents - (Value) | source1 |
| Documents 1: Title - (Value) | A small-scale ‘Development Impact Bond’ for hepatitis C diagnosis and treatment financing in Cameroon: the way to elimination? |
| Documents 1: URL - (Value) | https://www.joghr.org/article/90723-a-small-scale-development-impact-bond-for-hepatitis-c-diagnosis-and-treatment-financing-in-cameroon-the-way-to-elimination |